INHIBITION OF METASTATIC SPREAD BY ICRF159 - SELECTIVE DELETION OF A MALIGNANT CHARACTERISTIC

被引：98

作者：

SALSBURY, AJ

BURRAGE, K

HELLMANN, K

机构：

来源：

关键词：

D O I：

10.1136/bmj.4.5731.344

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：344 / &

共 14 条

[1] BURRAGE K, 1970, BRIT J PHARMACOL, V39, pP205
[2] ANTITUMOUR ACTIVITY IN A SERIES OF BISDIKETOPIPERAZINES
CREIGHTON, AM
HELLMANN, K
WHITECROSS, S
[J]. NATURE, 1969, 222 (5191) : 384 - +
[3] DONELLI MG, 1969, CANCER RES, V29, P414
[4] HANDLER AH, 1964, ACTA UNION INT CONTR, V20, P176
[5] HELLMANN K, 1970, J NATL CANCER I, V44, P539
[6] CONTROL OF MALIGNANT METASTASES BY ICRF-159
HELLMANN, K
BURRAGE, K
[J]. NATURE, 1969, 224 (5216) : 273 - &
[7] ANTITUMOUR ACTIVITY OF A SERIES OF BENZOTHIOPHENES
HELLMANN, K
MARSHALL, PG
STAYT, S
[J]. BIOCHEMICAL PHARMACOLOGY, 1967, 16 (04) : 681 - &
[8] PRELIMINARY CLINICAL ASSESSMENT OF ICRF 159 INACUTE LEUKAEMIA AND LYMPHOSARCOMA
HELLMANN, K
NEWTON, KA
WHITMORE, DN
HANHAM, IWF
BOND, JV
[J]. BRITISH MEDICAL JOURNAL, 1969, 1 (5647) : 822 - &
[9] HIGGINS GA, 1968, SURG CLIN N AM, V48, P839
[10] EXPERIMENTAL STUDY OF METASTASES
KETCHAM, AS
WEXLER, H
MINTON, JP
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1966, 198 (02) : 157 - +